US stock futures flounder amid tech weakness, Fed caution
Investing.com - Alx Oncology reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Alx Oncology announced earnings per share of $-0.87 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.81 on revenue of $0.00.
Alx Oncology 's are down 48.09% and is trading at $12.50 , still down 73.42% from its 52 week high of $47.03 set on Monday, November 15, 2021.
Alx Oncology follows other major Healthcare sector earnings this month
Alx Oncology's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar